Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00411684 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of CDB-2914 for Emergency Contraception
A Phase 3 study of Emergency Contraception, sponsored by HRA Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,623
- Enrollment target
- 17
- Study locations
NCT00411684: Completed Phase 3 study of Emergency Contraception, sponsored by HRA Pharma.
NCT00411684 is a Phase 3 study of Emergency Contraception that has completed, run by HRA Pharma. The registered enrollment target is 1,623 participants, above the 1,164-participant average among 3 other Emergency Contraception trials with a reported enrollment target (39% higher). The trial reports 17 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00411684, a Phase 3 study of Emergency Contraception, has completed, sponsored by HRA Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,623 participants
- Enrollment target
- 17
- Study locations
Study Summary
The purpose of this study is to assess the safety and efficacy of CDB-2914 for preventing pregnancy when taken 3 to 5 days after unprotected sexual intercourse.
Primary Outcome
A high sensitivity pregnancy test was performed at inclusion (between 48h and 120h after unprotected intercourse) and then until menses occured or up to 60 days if they did not, at the following time points: * 5-7 days after expected date of menses * 1 week later * every two week after
Conditions Studied
Interventions
- DRUG CDB-2914
Study Locations (17)
Florida
- Planned Parenthood of Greater Miami, Palm Beach and Treasure Cost - Miami
- Planned Parenthood of South Palm Beach, Pembroke Pines - Pembroke Pines
Texas
- Planned Parenthood of the Texas Capital Region - Austin
- Planned Parenthood of Houston and Southeast Texas - Houston
California
- Planned Parenthood of Mar Monte - San Jose
Colorado
- Planned Parenthood of the Rocky Mountains - Denver
Indiana
- Planned Parenthood of Indiana - Bloomington
Iowa
- Planned Parenthood of Greater Iowa - Ames
Maryland
- Planned Parenthood of Maryland - Baltimore
Massachusetts
- Planned Parenthood League of Massachusetts - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,623 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-06-05 |
| Phase | Phase 3 |
What the finished NCT00411684 record still lists
NCT00411684 is an interventional study that assigns participants to a tested intervention. Its 1,623 participants enrollment target places it among the larger protocols in the corpus, above the 1,164-participant average among 3 other Emergency Contraception trials with a reported enrollment target (39% higher).
The record links to 1 condition, with Emergency Contraception appearing as the primary indexed condition, and to 1 intervention - of which CDB-2914 is the first listed.
NCT00411684 lists 17 locations in 15 states (Florida, Texas, California).
Frequently Asked Questions
What is clinical trial NCT00411684 about?
NCT00411684 is a clinical study titled "Safety and Efficacy of CDB-2914 for Emergency Contraception". The purpose of this study is to assess the safety and efficacy of CDB-2914 for preventing pregnancy when taken 3 to 5 days after unprotected sexual intercourse.
What is the current status of trial NCT00411684?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,623 participants. The study started on 2006-11. Estimated completion is 2009-06-05.
What conditions does trial NCT00411684 study?
This clinical trial studies the following conditions: Emergency Contraception.
What interventions are being tested in trial NCT00411684?
The interventions under investigation include: CDB-2914 (DRUG).
Who is sponsoring clinical trial NCT00411684?
This trial is sponsored by HRA Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00411684 being conducted?
This trial has 17 study locations across California, Colorado, Florida, Indiana, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emergency Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06959524 · 1,616 participants · NA
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- NCT06271590 · 1,605 participants · NA
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia